Update: J&J COVID vaccine rollout paused as clot concerns spreadUS health authorities have recommended pausing dosing with Johnson & Johnson’s COVID-19 vaccine as they investigate cases of Share XUpdate: J&J COVID vaccine rollout paused as clot concerns spreadhttps://pharmaphorum.com/news/us-seeks-halt-on-jj-covid-vaccine-rollout-as-clot-concerns-spread/
AZ exits US vaccine plant after mix-up spoils J&J’s COVID jabAstraZeneca is shifting production of its COVID-19 vaccine away from a plant in Baltimore which also makes Johnson Share XAZ exits US vaccine plant after mix-up spoils J&J’s COVID jabhttps://pharmaphorum.com/news/az-exits-us-vaccine-plant-after-mix-up-spoils-jjs-covid-jab/
Haven: The strategy that didn’t fix healthcareJohn Singer discusses the disbanding of Haven, the joint healthcare venture by Amazon, JP Morgan and Berkshire Hathaway, Share XHaven: The strategy that didn’t fix healthcarehttps://pharmaphorum.com/views-analysis-market-access/haven-strategy-healthcare/
US eyes permanent change to digital health regulatory pathDevelopers of digital health tools have benefited from a truncated route to market during the COVID-19 crisis, and Share XUS eyes permanent change to digital health regulatory pathhttps://pharmaphorum.com/news/us-eyes-permanent-change-to-digital-health-regulatory-path/
Amgen’s Enbrel heads ICER list of unjustified US price risesUS cost effectiveness watchdog ICER found 10 examples of substantial price rises for top-selling medicines in 2019, and Share XAmgen’s Enbrel heads ICER list of unjustified US price riseshttps://pharmaphorum.com/news/icer-lists-top-unjustified-drug-price-rises-headed-by-amgens-enbrel/
Pfizer/BioNTech COVID-19 vaccinations start across the USHospitals in the US have started vaccinating their front-line staff against COVID-19, as deaths in the country crossed Share XPfizer/BioNTech COVID-19 vaccinations start across the UShttps://pharmaphorum.com/news/pfizer-biontech-covid-19-vaccinations-start-across-the-us/
As COVID-19 cases swell, US extends telehealth to acute careThe US government has introduced a scheme to allow hospitals to reduce the number of inpatients they see Share XAs COVID-19 cases swell, US extends telehealth to acute carehttps://pharmaphorum.com/news/as-covid-19-cases-swell-us-extends-telehealth-to-acute-care/
US buys Lilly COVID antibody, as effectiveness questions remainThe US government said it will buy 300,000 doses of Eli Lilly’s COVID-19 therapy bamlanivimab for $375 million Share XUS buys Lilly COVID antibody, as effectiveness questions remainhttps://pharmaphorum.com/news/us-buys-300000-doses-lilly-covid-antibody/
Purdue to pay $8.3bn after admitting criminal charges in opioid caseAfter years of legal wrangling, Purdue Pharma has agreed a deal to resolve litigation about its role in Share XPurdue to pay $8.3bn after admitting criminal charges in opioid casehttps://pharmaphorum.com/news/purdue-to-pay-8-3bn-after-admitting-criminal-charges-in-opioid-case/
